Fortis Healthcare Approves FY26 Audited Results and Recommends ₹1 Dividend
Fortis Healthcare announced audited standalone and consolidated financial results for the year ended March 31, 2026. The company recommended a final dividend of ₹1 per equity share for FY26. M/s Jitender, Navneet & Co. were appointed as Cost Auditors for FY27. The Board Meeting concluded on May 22, 2026.
The approval of financial results and recommendation of dividend are significant events for the company and its shareholders, impacting investor confidence.
The company reported audited financial results and recommended a dividend, which are generally viewed positively by investors.
Fortis Healthcare Limited announced the outcome of its Board Meeting held on May 22, 2026. The Board approved the standalone and consolidated audited financial results for the quarter and financial year ended March 31, 2026. The company's statutory auditors, B S R & Co. LLP, issued an audit report with an unmodified opinion.
Additionally, the Board recommended a final dividend of ₹1 per equity share (10% of face value) for the financial year 2025-26, subject to shareholder approval. This dividend, if approved, will be paid/dispatched within 30 days from the conclusion of the ensuing Annual General Meeting.
The Board also approved the appointment of M/s Jitender, Navneet & Co., Cost Accountants, as the Cost Auditor for the Financial Year 2026-27. A policy for Corporate Social Responsibility was also approved.
The audited consolidated financial results for the quarter and year ended March 31, 2026, will be published in newspapers and will be available on the websites of the stock exchanges and the company. The Board Meeting commenced at 09:35 Hours IST and concluded at 19:35 Hours IST.
What to do with a filing like this
Fortis Healthcare Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Fortis Healthcare Limited. Read the original for the full detail.